Challenges in Monoclonal Antibody Purification
Monoclonal antibodies (mAbs) have revolutionized the field of medicine, finding applications in various therapeutic areas. Their purification is a critical step in the bioprocessing of mAbs, ensuring their safety and efficacy. However, the purification process is fraught with several challenges that demand innovative solutions.
One major hurdle is the complexity of the mAb molecule itself. Its large size and glycosylation patterns can hinder its interaction with purification matrices, leading to low recovery yields. Additionally, the presence of impurities, such as host cell proteins and nucleic acids, can interfere with the purification process and compromise the final product quality. Another challenge arises from the scale of mAb production. As demand for mAbs increases, purification processes must be scaled up while maintaining high purity and yield. This requires specialized equipment and optimized purification strategies.
Moreover, the regulatory landscape for mAb purification is stringent, demanding rigorous quality control measures. This necessitates the implementation of robust analytical techniques to ensure the removal of impurities and the verification of product specifications. The cost of mAb purification is also a significant consideration, as it can impact the overall profitability of the process. Developing efficient and cost-effective purification methods is essential for the commercial success of mAbs.
Visit our website to know more: https://www.leadventgrp.com/events/2nd-annual-bioprocessing-and-biologics-forum/details
For more information and group participation, contact us: [email protected]
Leadvent Group - Industry Leading Events for Business Leaders!
www.leadventgrp.com| [email protected]
